Data for Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure (Study ST001140)
(Analysis AN001873)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 |
---|---|---|---|---|
TG(46:1) | 1.2704 | 0.7296 | NA | NA |
TG(46:2) | 1.6215 | 0.8926 | 0.4162 | 0.8984 |
TG(48:0) | 0.9491 | 1.0509 | NA | NA |
TG(48:1) | 1.1243 | 1.1869 | 0.3967 | 1.1883 |
TG(48:2) | 1.4656 | 1.0550 | 0.3372 | 0.9688 |
TG(48:3) | 1.5774 | 0.7750 | 0.5809 | 0.9492 |
TG(50:0) | 0.9843 | 1.3838 | 0.1424 | 1.3669 |
TG(50:1) | 1.2208 | 1.0803 | 0.1774 | 1.4212 |
TG(50:2) | NA | NA | 0.4643 | 1.5357 |
TG(50:3) | NA | NA | 0.4772 | 1.5228 |
TG(50:4) | 1.4163 | 0.6027 | 0.5537 | 1.4210 |
TG(51:0) | 0.8627 | 1.2483 | 0.2503 | 1.4768 |
TG(51:1) | 1.0660 | 1.0288 | 0.1472 | 1.7264 |
TG(51:2) | 1.0634 | 0.9207 | 0.3265 | 1.6946 |
TG(51:3) | 1.0848 | 0.8593 | 0.3877 | 1.6868 |
TG(52:1) | 1.1337 | 0.9925 | 0.1397 | 1.6920 |
TG(52:2) | 1.0844 | 0.9598 | 0.3693 | 1.5717 |
TG(52:3) | 1.2117 | 1.0136 | 0.6166 | 1.0830 |
TG(52:4) | 1.2891 | 0.8759 | 0.5516 | 1.2284 |
TG(52:5) | NA | NA | 0.7043 | 1.2957 |
TG(53:2) | 1.0083 | 0.5975 | 0.2517 | 2.2739 |
TG(54:1) | NA | NA | 0.0853 | 1.9147 |
TG(54:2) | 1.1644 | 0.7929 | 0.1427 | 1.9142 |
TG(54:3) | 1.1655 | 0.8052 | 0.2904 | 1.7487 |
TG(54:4) | 1.1881 | 0.8953 | 0.3520 | 1.5369 |
TG(54:5) | 1.0293 | 1.0985 | 0.3365 | 1.4931 |
TG(54:6) | NA | NA | 0.6975 | 1.3025 |
TG(55:0) | 1.0519 | 0.7794 | 0.5623 | 1.6625 |
TG(55:1) | 1.0913 | 0.6785 | 0.8612 | 1.4457 |
TG(56:5) | NA | NA | 0.5709 | 1.4291 |
TG(56:6) | 1.2520 | 0.8337 | 0.5627 | 1.3230 |
TG(57:1) | NA | NA | 0.3797 | 1.7443 |
TG(57:3) | NA | NA | 1.2417 | 0.7583 |
Factors:
F1 | TreatmentGroup:Prednisolone | TreatmentDuration:0d | SamplingTimePoint:before |
F2 | TreatmentGroup:Prednisolone | TreatmentDuration:4d | SamplingTimePoint:after |
F3 | TreatmentGroup:Tetracosactide | TreatmentDuration:00w | SamplingTimePoint:before |
F4 | TreatmentGroup:Tetracosactide | TreatmentDuration:25w | SamplingTimePoint:after |